The coagulation system and pulmonary endothelial function in acute lung injury

Microvascular Research

Volumn 77, Issue 1, 2009, Pages 35-38

  Finigan, James H ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Activated protein C; Acute lung injury; Endothelial permeability; Endothelial protein C receptor; Tissue factor

Indexed keywords

ACTIN; ACTIVATED PROTEIN C; ANTICOAGULANT PROTEIN; ENDOTHELIAL PROTEIN C RECEPTOR; PROTEIN C; THROMBIN; THROMBOPLASTIN;

ACUTE LUNG INJURY; BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; CYTOSKELETON; HUMAN; INFLAMMATION; LUNG ENDOTHELIUM; LUNG FUNCTION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SEPSIS; VASCULAR ENDOTHELIUM;

ACUTE LUNG INJURY; ANIMALS; BLOOD COAGULATION; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; HUMANS; LUNG; PROTEIN C; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 59849109478     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.09.002     Document Type: Review

References (59)

1. Abraham E., et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290 2 (2003) 238-247
2. Abraham E., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med. 353 13 (2005) 1332-1341
3. Bae J.S., Yang L., and Rezaie A.R. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc. Natl Acad. Sci. U. S. A. 104 8 (2007) 2867-2872
4. Bae J.S., and Rezaie A.R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 100 1 (2008) 101-109
5. Bernard G.R., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 10 (2001) 699-709
6. Birukov K.G., et al. Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch. Am. J. Physiol. Lung Cell Mol. Physiol. 285 4 (2003) L785-L797
7. Bone R.C., Francis P.B., and Pierce A.K. Intravascular coagulation associated with the adult respiratory distress syndrome. Am. J. Med. 61 5 (1976) 585-589
8. Branson H.E., et al. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 2 8360 (1983) 1165-1168
9. Burden-Gulley S.M., and Brady-Kalnay S.M. PTPmu regulates N-cadherin-dependent neurite outgrowth. J. Cell Biol. 144 6 (1999) 1323-1336
10. Cheng T., et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat. Med. 9 3 (2003) 338-342
11. Conway E.M., et al. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb. Res. 53 3 (1989) 231-241
12. Creasey A.A., et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J. Clin. Invest. 91 6 (1993) 2850-2860
13. Dahlem P., et al. Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation. Intensive Care Med. 31 5 (2005) 724-732
14. Derhaschnig U., et al. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102 6 (2003) 2093-2098
15. Dudek S.M., and Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91 4 (2001) 1487-1500
16. Dudek S.M., et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J. Biol. Chem. 279 23 (2004) 24692-24700 (2004 Jun 4)
17. Feistritzer C., and Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105 8 (2005) 3178-3184
18. Fincham V.J., and Frame M.C. The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J. 17 1 (1998) 81-92
19. Finigan J.H., et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J. Biol. Chem. 280 17 (2005) 17286-17293
20. Finigan J.H., et al. The endothelial protein C receptor plays a key role in ventilator-induced lung injury and activated protein C-mediated protection. Am. J. Respir. Crit. Care Med. 177 Abstract Issue (2008) A765
21. Freshney N.W., et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78 6 (1994) 1039-1049
22. Fukuda Y., et al. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126 1 (1987) 171-182
23. Fukudome K., and Esmon C.T. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J. Biol. Chem. 269 42 (1994) 26486-26491
24. Furie B., and Furie B.C. In vivo thrombus formation. J. Thromb. Haemost. 5 Suppl. 1 (2007) 12-17
25. Garcia J.G., and Schaphorst K.L. Regulation of endothelial cell gap formation and paracellular permeability. J. Investig. Med. 43 2 (1995) 117-126
26. Garcia J.G., et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108 5 (2001) 689-701
27. Griffin J.H., et al. Deficiency of protein C in congenital thrombotic disease. J. Clin. Invest. 68 5 (1981) 1370-1373
28. Grigoryev D.N., et al. Orthologous gene-expression profiling in multi-species models: search for candidate genes. Genome Biol 5 5 (2004) R34
29. Grinnell F., Feld M., and Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin). Cell 19 2 (1980) 517-525
30. Hesselvik J.F., et al. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb. Haemost. 65 2 (1991) 126-129
31. Hudson L.D., et al. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151 2 Pt 1 (1995) 293-301
32. Idell S., et al. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am. J. Physiol. 261 4 Pt 1 (1991) L240-L248
33. Isermann B., et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat. Med. 13 11 (2007) 1349-1358
34. Jacobson J.R., et al. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am. J. Respir. Cell Mol. Biol. 30 5 (2003) 662-670 (2004 May)
35. Jenkins R.G., et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J. Clin. Invest. 116 6 (2006) 1606-1614
36. Kalil A.C., et al. Effects of drotrecogin alfa (activated) in human endotoxemia. Shock 21 3 (2004) 222-229
37. Kaneider N.C., et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat. Immunol. 8 12 (2007) 1303-1312
38. Kurosawa S., et al. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91 2 (1998) 725-727
39. Levi M., et al. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees. Am. J. Respir. Crit. Care Med. 158 1 (1998) 92-98
40. Liaw P.C., et al. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J. Biol. Chem. 275 8 (2000) 5447-5452
41. Liu K.D., et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am. J. Respir. Crit. Care Med. 178 6 (2008) 618-623 (2008 Sep 15)
42. Nagy Z., et al. Contraction of human brain endothelial cells induced by thrombogenic and fibrinolytic factors. An in vitro cell culture model. Stroke 26 2 (1995) 265-270
43. Oganesyan V., et al. The crystal structure of the endothelial protein C receptor and a bound phospholipid. J. Biol. Chem. 277 28 (2002) 24851-24854
44. Peng X., et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169 11 (2004) 1245-1251
45. Peng X., et al. Inducible nitric oxide synthase contributes to ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 172 4 (2005) 470-479
46. Riewald M., et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296 5574 (2002) 1880-1882
47. Roupie E., et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. SRLF Collaborative Group on Mechanical Ventilation. Societe de Reanimation de Langue Francaise. Intensive Care Med. 25 9 (1999) 920-929
48. Rubenfeld G.D., et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353 16 (2005) 1685-1693
49. Saldeen T., and Uppsala universitet. The Microembolism Syndrome 8 (1979), Almqvist & Wiksell international, Stockholm 239
50. Seligsohn U., et al. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N. Engl. J. Med. 310 9 (1984) 559-562
51. Singleton P.A., et al. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 19 12 (2005) 1646-1656
52. Taylor Jr. F.B., et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 79 3 (1987) 918-925
53. Taylor Jr. F.B., et al. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97 6 (2001) 1685-1688
54. Uchiba M., et al. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. Am. J. Physiol. 271 3 Pt 1 (1996) L470-L475
55. Vestweber D. Molecular mechanisms that control endothelial cell contacts. J. Pathol. 190 3 (2000) 281-291
56. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342 18 (2000) 1334-1349
57. Warren B.L., et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286 15 (2001) 1869-1878
58. Xu J., et al. Metalloproteolytic release of endothelial cell protein C receptor. J. Biol. Chem. 275 8 (2000) 6038-6044
59. Yan S.B., et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120 3 (2001) 915-922